Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters

The biosimilar concept is now well established. Clinical data accumulated pre- and post-approval have supported biosimilar uptake, in turn stimulating competition in the biologics market and increasing patient access to biologics. Following technological advances, other innovative biologics, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, HoUng, Alten, Rieke, Cummings, Fraser, Danese, Silvio, D’Haens, Geert, Emery, Paul, Ghosh, Subrata, Gilletta de Saint Joseph, Cyrielle, Lee, JongHyuk, Lindsay, James O., Nikiphorou, Elena, Parker, Ben, Schreiber, Stefan, Simoens, Steven, Westhovens, Rene, Jeong, Ji Hoon, Peyrin-Biroulet, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889098/
https://www.ncbi.nlm.nih.gov/pubmed/33557682
http://dx.doi.org/10.1080/19420862.2020.1868078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889098/
https://www.ncbi.nlm.nih.gov/pubmed/33557682
http://dx.doi.org/10.1080/19420862.2020.1868078

Ejemplares similares